Trials / Conditions / Leiomyosarcoma (LMS)
Leiomyosarcoma (LMS)
4 registered clinical trials studyying Leiomyosarcoma (LMS) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarc NCT07173972 | Oslo University Hospital | Phase 2 |
| Active Not Recruiting | Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subj NCT05827614 | Boundless Bio, Inc. | Phase 1 |
| Recruiting | Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932 | Royal Marsden NHS Foundation Trust | — |
| No Longer Available | Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignan NCT02822495 | Atara Biotherapeutics | — |